These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11870803)
1. Application of tissue-marking ink to prostate biopsy specimens. Terris MK; McNeal JE Prostate; 2002 Mar; 50(4):247-51. PubMed ID: 11870803 [TBL] [Abstract][Full Text] [Related]
2. Use of tissue ink to maintain identification of individual cores on needle biopsies of the prostate. Singh PB; Saw NK; Haq A; Blades RA; Martin FL; Matanhelia SS; Nicholson CM J Clin Pathol; 2008 Sep; 61(9):1055-7. PubMed ID: 18641411 [TBL] [Abstract][Full Text] [Related]
4. The effectiveness of inking needle core prostate biopsies for preventing patient specimen identification errors: a technique to address Joint Commission patient safety goals in specialty laboratories. Raff LJ; Engel G; Beck KR; O'Brien AS; Bauer ME Arch Pathol Lab Med; 2009 Feb; 133(2):295-7. PubMed ID: 19195973 [TBL] [Abstract][Full Text] [Related]
5. The value of inking breast cores to reduce specimen mix-up. Renshaw AA; Kish R; Gould EW Am J Clin Pathol; 2007 Feb; 127(2):271-2. PubMed ID: 17210528 [TBL] [Abstract][Full Text] [Related]
6. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen. Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195 [TBL] [Abstract][Full Text] [Related]
7. Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores. Grossklaus DJ; Coffey CS; Shappell SB; Jack GS; Cookson MS BJU Int; 2001 Nov; 88(7):722-6. PubMed ID: 11890243 [TBL] [Abstract][Full Text] [Related]
8. Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score? Kunju LP; Daignault S; Wei JT; Shah RB Hum Pathol; 2009 Apr; 40(4):558-64. PubMed ID: 19144380 [TBL] [Abstract][Full Text] [Related]
9. Optimal combinations for detection of prostate cancer: systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies. Kravchick S; Cytron S; Peled R; London D; Sibi Y; Ben-Dor D Urology; 2004 Feb; 63(2):301-5. PubMed ID: 14972476 [TBL] [Abstract][Full Text] [Related]
10. Prostate sampling by 12-core biopsy: comparison of the biopsy results with tumor location in prostatectomy specimens. Iremashvili V; Pelaez L; Jorda M; Manoharan M; Arianayagam M; Rosenberg DL; Soloway MS Urology; 2012 Jan; 79(1):37-42. PubMed ID: 22055691 [TBL] [Abstract][Full Text] [Related]
11. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Epstein JI; Amin MB; Reuter VE; Humphrey PA Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964 [TBL] [Abstract][Full Text] [Related]
12. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Naughton CK; Smith DS; Humphrey PA; Catalona WJ; Keetch DW Urology; 1998 Nov; 52(5):808-13. PubMed ID: 9801104 [TBL] [Abstract][Full Text] [Related]
13. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Nelson ED; Slotoroff CB; Gomella LG; Halpern EJ Urology; 2007 Dec; 70(6):1136-40. PubMed ID: 18158034 [TBL] [Abstract][Full Text] [Related]
14. Is extended 11-core biopsy valuable in benign prostatic hyperplasia patients with intermediate serum prostate-specific antigen (4.1-10 ng/ml) and prior negative sextant biopsy? Abdel-Khalek M; El-Baz M; Ibrahiem el-H Scand J Urol Nephrol; 2004; 38(4):315-20. PubMed ID: 15669591 [TBL] [Abstract][Full Text] [Related]
15. Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer. Moussa AS; Meshref A; Schoenfield L; Masoud A; Abdel-Rahman S; Li J; Flazoura S; Magi-Galluzzi C; Fergany A; Fareed K; Jones JS Urology; 2010 May; 75(5):1034-9. PubMed ID: 20080294 [TBL] [Abstract][Full Text] [Related]
16. Precise preoperative localization of prostate cancer employing 12-core needle biopsy with a tissue-marking method for effective surgical strategy. Sato S; Watanabe M; Taniuchi S; Kasajima A; Mitsuzuka K; Nakamura Y; Fujishima F; Arai Y; Sasano H Tohoku J Exp Med; 2015 May; 236(1):55-61. PubMed ID: 25971922 [TBL] [Abstract][Full Text] [Related]
17. Significance of routine transition zone biopsies in Japanese men undergoing transrectal ultrasound-guided prostate biopsies. Miyake H; Kurahashi T; Muramaki M; Yamanak K; Hara I Int J Urol; 2005 Nov; 12(11):964-8. PubMed ID: 16351652 [TBL] [Abstract][Full Text] [Related]
18. [Individualization of transrectal ultrasonography-guided prostate biopsy for prostate cancer detection]. Liang H; Qiu SP; Zheng KL; Wu RP Ai Zheng; 2007 May; 26(5):552-4. PubMed ID: 17672951 [TBL] [Abstract][Full Text] [Related]
19. Simulation of microcalcifications on specimen radiographs of breast biopsies by inks used in marking the surgical resection margins. Wong JW; Bai H; Abdul-Karim FW; MacLennan GT Breast J; 2004; 10(5):423-6. PubMed ID: 15327496 [TBL] [Abstract][Full Text] [Related]
20. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes]. Damiano R; Oliva A; Cantiello F; Esposito C; PerdonĂ S; De Sio M; Bitonti M; Sacco R; D'Armiento M Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]